|1.||van Broekhoven, Christina L: 2 articles (10/2005 - 03/2002)|
|2.||Altin, Joseph G: 2 articles (10/2005 - 03/2002)|
|3.||Altin, J G: 2 articles (08/2001 - 03/2000)|
|4.||Easton, C J: 1 article (08/2001)|
|5.||White, F A: 1 article (08/2001)|
|6.||Vassiliou, G: 1 article (03/2000)|
|7.||Parish, C R: 1 article (03/2000)|
|8.||van Broekhoven, C L: 1 article (03/2000)|
03/01/2000 - "Initial experiments using murine P815 tumor cells established the optimum conditions for incorporating NTA-DTDA onto the membranes of cells. "
03/01/2000 - "A novel chelator lipid, nitrilotriacetic acid di-tetradecylamine (NTA-DTDA) that, via the NTA group has high affinity for 6His peptide, was used to directly anchor recombinant forms of T cell costimulatory molecules containing a C-terminal 6-His sequence onto tumor cell surfaces. "
10/15/2005 - "Recent studies indicate that the chelator lipid nitrilotriacetic acid ditetradecylamine (NTA-DTDA) can be used to engraft T cell costimulatory molecules onto tumor cell membranes, potentially circumventing the need for genetic manipulation of the cells for development of cell- or membrane-based tumor vaccines. "
03/01/2002 - "Our analyses by flow cytometry show that NTA-DTDA can be incorporated into PMV prepared from murine P815 mastocytoma and that the incorporated NTA-DTDA permits anchoring or "engraftment" onto the vesicle surface of hexahistidine-tagged proteins such as recombinant forms of the costimulatory molecules B7.1 and CD40. "
|3.||AIDS-Related Complex (ARC)
|1.||nitrilotriacetic acid ditetradecylamine
|3.||Proteins (Proteins, Gene)